AUL
ABBV icon

AlphaGrep UK Ltd’s AbbVie ABBV Stock Holding History

AlphaGrep UK Ltd’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$304K Sell
1,399
-1,741
-55% -$386K 0.09% 499
2025
Q4 		$717K Buy
+3,140
New +$715K 0.24% 96

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AlphaGrep UK Ltd's ABBV Position: Q1 2026 in Review

AlphaGrep UK Ltd reduced its AbbVie (ABBV) stake by 55% in Q1 2026, selling an estimated $386K and leaving 1,399 shares worth $304K. The position accounts for 0.09% of the portfolio, ranked #499.

AlphaGrep UK Ltd first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. The position peaked at $717K in Q4 2025. 4,092 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • AlphaGrep UK Ltd held 1,399 shares of AbbVie worth $304K as of Q1 2026.
  • AlphaGrep UK Ltd sold 1,741 AbbVie shares in Q1 2026, an estimated $386K.
  • AbbVie made up 0.09% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #499 holding.
  • AlphaGrep UK Ltd first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
  • AlphaGrep UK Ltd's AbbVie position peaked at $717K in Q4 2025.
  • 4,092 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.